RB1 and melanoma: Interestingly, KYNA in the highest tested concentration (5 mM) decreased CDK4 protein level and phosphorylation of Rb in A375 cells (Figure 3b), despite no significant changes in proliferation (DNA synthesis) of KYNA-treated A375 melanoma cells.